Tag Archives: ANVISA

SeeThruEquity RSHO Raúl Elizalde

Medical Marijuana, Inc. Receives Brazilian Government Approval for Treatment of Autism Patient Using, Subsidiary, HempMeds® Brasil, Flagship Product RSHO™

Medical Marijuana, Inc. Receives Brazilian Government Approval for Treatment of Autism Patient Using, Subsidiary, HempMeds® Brasil, Flagship Product RSHO™

SAN DIEGO, Calif., March 3, 2017/Weed Wire/ — Medical Marijuana, Inc. (MJNA), the first publicly traded cannabis company in the United States subsidiary, HempMeds® Brasil, today announced that the Brazilian government approved a prescription for the Company’s cannabidiol (CBD) oil product Real Scientific Hemp Oil™ (RSHO™) to treat a patient in the country with Autism Spectrum Disorder (ASD).

Olá R&D: Bedrocan Canada Exports Medical Cannabis to Brazil

Olá R&D: Bedrocan Canada Exports Medical Cannabis to Brazil

On Nov. 23, 2016, Canopy Growth Corporation (TSX:CGC) announced that Bedrocan Canada, one of its subsidiaries, had completed its first export of cannabis to South America, shipping 10 kg of dried cannabis to Brazil for the research and development of cannabis-based therapeutics in the country.

MJNA and AXIM

Brazil’s Government Health Agency Approves Patient’s Request for Medical Marijuana, Inc.’s RSHO™ for a New Indication: Parkinson’s Disease

SAN DIEGO,Nov. 18, 2015 /Weed Wire/ — Medical Marijuana, Inc. is pleased to announce to shareholders and to the public that its flagship product Real Scientific Hemp Oil™ (RSHO™) has been approved on a case-by-case basis for Parkinson’s disease by the Brazilian Government Health Agency ANVISA.


Top